Essais liés3clinical trials
VilleKocaelilocalisation
PaysTurkey (Türkiye)localisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07282574

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
RO7268489 SEP Phase 2 NCT07282574 Mintaka — A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) RECRUITING
Povetacicept Myasthénie Phase 2 NCT07501702 ETNA — A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis ACTIVE_NOT_RECRUITING
Interferon beta-1a SEP Phase 3 NCT01412333 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis COMPLETED